Stockscreener 앱 받기
0.1703
0.53%
-0.0009
시간 외 거래:
.17
-0.0003
-0.18%
전일 마감가:
$0.1712
열려 있는:
$0.1712
하루 거래량:
868.07K
Relative Volume:
0.17
시가총액:
$9.40M
수익:
$9.00M
순이익/손실:
$-7.21M
주가수익비율:
-0.3096
EPS:
-0.55
순현금흐름:
$-7.59M
1주 성능:
-4.33%
1개월 성능:
-29.16%
6개월 성능:
-57.43%
1년 성능:
-98.49%
1일 변동 폭
$0.17
$0.173
1주일 범위
$0.165
$0.1784
52주 변동 폭
$0.1204
$14.40
Applied Dna Sciences Inc Stock (APDN) Company Profile
명칭
Applied Dna Sciences Inc
전화
631-240-8800
주소
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
APDN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
0.1703 | 9.40M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
572.71 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.01 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.64 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
209.96 | 38.11B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
460.56 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-02-12 | 개시 | ROTH Capital | Buy |
| 2021-01-14 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-02 | 개시 | H.C. Wainwright | Buy |
| 2016-11-14 | 재확인 | Maxim Group | Buy |
| 2016-05-13 | 재확인 | Maxim Group | Buy |
| 2015-10-08 | 재확인 | Maxim Group | Buy |
| 2015-05-26 | 개시 | The Benchmark Company | Speculative Buy |
| 2015-02-10 | 재확인 | Maxim Group | Buy |
| 2015-01-13 | 개시 | Maxim Group | Buy |
모두보기
Applied Dna Sciences Inc 주식(APDN)의 최신 뉴스
A History of Outperforming Analyst Forecasts and Beating the Odds: Applied Dna Sciences Inc (APDN) - SETE News
Breaking down APDN’s current quarter earnings estimates - US Post News
Applied DNA Sciences Announces Change in Certifying Accountant – Form 8-K Filing - Defense World
Applied DNA Sciences Appoints New Auditor By Investing.com - Investing.com South Africa
Applied DNA Sciences Appoints New Auditor - Investing.com
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health - ACCESS Newswire
Applied DNA Sciences, Inc. to Host Earnings Call - ACCESS Newswire
Applied DNA Sciences Holds Special Meeting of Stockholders - Defense World
Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit - ACCESS Newswire
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines - ACCESS Newswire
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement - ACCESS Newswire
Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress - ACCESS Newswire
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates - ACCESS Newswire
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out - ACCESS Newswire
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing - ACCESS Newswire
Applied DNA Sciences fails to secure shareholder vote - MSN
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 - ACCESS Newswire
Applied DNA Sciences fails to secure shareholder vote By Investing.com - Investing.com Australia
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA - ACCESS Newswire
Applied DNA Launches Mpox Clade I and Clade II Testing Service - ACCESS Newswire
Applied DNA Announces 1-For-20 Reverse Stock Split - ACCESS Newswire
Short Interest in Applied DNA Sciences, Inc. (NASDAQ:APDN) Drops By 5.1% - Defense World
73,396 Shares in Applied DNA Sciences, Inc. (NASDAQ:APDN) Purchased by Jane Street Group LLC - Defense World
Applied DNA Sciences Utilizes Company Presentation for Investor Outreach - Defense World
Applied DNA Sciences Advances in Genetic Medicines Market - TipRanks
APDNApplied DNA Sciences, Inc. Latest Stock News & Market Updates - StockTitan
Applied DNA Sciences Completes GMP Facility for mRNA Production, Eyes $30M Revenue Potential - StockTitan
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter - Weatherford Democrat
Applied DNA Sciences Reschedules Q1 2025 Earnings Call and Strategic Update to February 13 - StockTitan
SABBY MANAGEMENT, LLC Acquires Significant Stake in Applied DNA Sciences Inc - GuruFocus.com
Featured Company NewsApplied DNA Sciences Enters into CertainT Trademark License Agreement with Techmer PM - AccessWire
When Would Be The Best Time To Buy Applied Dna Sciences Inc (NASDAQ: APDN) Stock? - Stocks Register
Applied DNA Sciences Secures Landmark Approval for Revolutionary CAR T-Cell Therapy Trial in Czech Republic - StockTitan
Why US Futures Are Rising WednesdayCorvus Pharma (NASDAQ:CRVS), Applied DNA Sciences (NASDAQ:APDN) - Benzinga
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday - Benzinga
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot - CT Insider
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Applied DNA Sciences Inc. (APDN) reports earnings - Quartz
Applied DNA Sciences Pivots to Genetic Medicine Manufacturing, Plans Major Restructuring Amid Revenue Drop - StockTitan
Applied DNA Sciences Sets Q4 Earnings Date, to Update on Key Manufacturing Expansion - StockTitan
APDN stock plunges to 52-week low of $0.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low of $0.15 amid market challenges - Investing.com
Applied DNA Sciences, Inc. (NASDAQ:APDN) Sees Large Decrease in Short Interest - Defense World
Analysts Predict How High Applied Dna Sciences Inc (APDN) Will Go. - Stocks Register
Applied DNA stock jumps amid U.S. government mpox update - MSN
Applied Dna Sciences Inc (APDN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.51%
자본화:
|
볼륨(24시간):